相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

生物标志物生物标志物

Stanley Williams¹, Samrah Siddiqi¹, Sulin Liu¹

¹UK Dementia Research Institute at Imperial College, LONDON, London, United Kingdom.

Alzheimer's & dementia : the journal of the Alzheimer's Association

|December 24, 2025

概括

突触损失是阿尔茨海默病 (AD) 的关键. 聚乙烯追踪器UCB-J针对SV2a,但SV2a不仅在突触上,限制了其作为AD突触密度生物标志物的使用.

科学领域:

神经科学是一个神经科学.
神经病理学神经病理学
生物标志物开发生物标志物开发

背景情况:

突触损失是阿尔茨海默病 (AD) 的标志,与认知能力下降相关.
PET 标记器 UCB-J 准 SV2a,一种被认为标记突触密度的蛋白质.
在突触外SV2a的存在使其作为可靠的AD生物标志物的解释变得复杂.

研究的目的:

为了研究SV2a.的细胞和亚细胞分布.
为了澄清大脑中SV2a的PET信号的来源.
评估SV2a作为阿尔茨海默病中突触密度生物标志物的实用性.

主要方法:

来自AD和对照对象的人类死后脑组织被染色为SV2a和各种突触和非突触标记物.
对焦成像和Imaris软件用于详细的细胞和亚细胞分析.
进行了局部化分析,以确定SV2a.的突触和非突触分布.

主要成果:

SV2a与突触标记物 (synaptophysin,VGLUT1,VGAT) 显示了部分局部化,表明它不在所有突触中存在.
在非突触神经元区 (轴突,体部区域) 和质细胞,特别是星球细胞中发现了显著比例的SV2a.
与对照人群相比,在AD皮质组织中,星体细胞中的SV2a水平升高.

结论:

SV2a不仅局限于突触,主要表达在神经元和质区.
SV2a的非突触分布表明,针对SV2a的PET标记物可能不会准确地反映阿尔茨海默病中的真实突触密度.
作为AD中突触损失的直接生物标志物,SV2a的实用性需要重新评估.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...